These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12657823

  • 1. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ.
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
    [Abstract] [Full Text] [Related]

  • 2. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
    Liang WF, Yang DH, Shen YH, Xie YJ, Zhao NF.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248
    [Abstract] [Full Text] [Related]

  • 3. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
    Hosseini SY, Sabahi F, Amini-Bavil-Olyaee S, Alavian SM, Merat S.
    J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
    [Abstract] [Full Text] [Related]

  • 4. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Takagi K, Kobayashi M, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Jan; 39(1):34-40. PubMed ID: 14767732
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
    Deng H, Lv Y, Fu J.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
    [Abstract] [Full Text] [Related]

  • 6. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
    Pan XP, Wo JE, Chen Z, Chen F, Liang WF, Liu KZ.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341
    [Abstract] [Full Text] [Related]

  • 7. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Oct; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 8. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Kobayashi M, Ikeda K, Miyakawa Y, Kumada H.
    J Med Virol; 2004 Oct; 74(2):361-6. PubMed ID: 15332287
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].
    Hu YY, Jiang JJ, Li D, Lin CW, Li QG, Chen Y.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):427-30. PubMed ID: 12890350
    [Abstract] [Full Text] [Related]

  • 10. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.
    Ramezani A, Velayati AA, Roshan MR, Gachkar L, Banifazl M, Keyvani H, Aghakhani A.
    Int J Infect Dis; 2008 May; 12(3):252-5. PubMed ID: 17954033
    [Abstract] [Full Text] [Related]

  • 11. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
    Ding C, Wong VW, Chow KC, Chan HY, Hui AY, Wong GL, Lo YM, Sung JJ, Chan HL.
    Antivir Ther; 2006 May; 11(8):1041-9. PubMed ID: 17302374
    [Abstract] [Full Text] [Related]

  • 12. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
    Ohishi W, Shirakawa H, Kawakami Y, Kimura S, Kamiyasu M, Tazuma S, Nakanishi T, Chayama K.
    J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
    Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM.
    Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384
    [Abstract] [Full Text] [Related]

  • 14. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
    Feng B, Wei L, Chen M, Wang L.
    Microbiol Res; 2008 Jan; 163(4):487-92. PubMed ID: 17317127
    [Abstract] [Full Text] [Related]

  • 15. Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy.
    Akuta N, Suzuki F, Kobayashi M, Matsuda M, Sato J, Takagi K, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2003 Dec; 71(4):504-10. PubMed ID: 14556262
    [Abstract] [Full Text] [Related]

  • 16. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
    Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, Abacioglu YH.
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
    [Abstract] [Full Text] [Related]

  • 17. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
    Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Murashima N, Ikeda K, Kumada H.
    Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
    [Abstract] [Full Text] [Related]

  • 18. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 19. [A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene].
    Ding JJ, Zhang WS, Zhang LS.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):24-7. PubMed ID: 15340520
    [Abstract] [Full Text] [Related]

  • 20. Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
    Yoshida S, Hige S, Yoshida M, Yamashita N, Fujisawa S, Sato K, Kitamura T, Nishimura M, Chuma M, Asaka M, Chiba H.
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):59-64. PubMed ID: 18275675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.